SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

ADMA Biologics Q1 EPS $(0.260) Misses $(0.120) Estimate, Sales $10.200M Miss $10.880M Estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.260) per share which missed the analyst consensus estimate of $(0.120) by 116.67 percent. This is a 7.14 percent increase over losses of $(0.280) per share

Benzinga · 05/06/2020 20:38

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.260) per share which missed the analyst consensus estimate of $(0.120) by 116.67 percent. This is a 7.14 percent increase over losses of $(0.280) per share from the same period last year. The company reported quarterly sales of $10.200 million which missed the analyst consensus estimate of $10.880 million by 6.25 percent. This is a 189.03 percent increase over sales of $3.529 million the same period last year.